-
1
Research Progress of ALK Activation Pattern Changes and Targeted Therapy in Advanced Lung Cancer
Published 2024-12-01Subjects: Get full text
Article -
2
Immunohistochemical expression of anaplastic lymphoma kinase in neuroblastoma and its relations with some clinical and histopathological features
Published 2024-01-01Subjects: Get full text
Article -
3
Regional reporting of the incidence of Anaplastic Lymphoma Kinase mutation in 379 non-small-cell lung cancer patients from Kolkata: Using immunohistochemistry as the diagnostic mod...
Published 2017-01-01Subjects: “…Anaplastic lymphoma kinase gene rearrangement…”
Get full text
Article -
4
Successful Conversion Surgery after Ceritinib Monotherapy in a Patient with Advanced Inflammatory Myofibroblastic Tumor Harboring SQSTM1-ALK fusion
Published 2024-06-01Subjects: “…anaplastic lymphoma kinase…”
Get full text
Article -
5
ALK-positive Large B-cell Lymphoma: A Clinicopathologic Retrospective Descriptive Study from a Tertiary Care Cancer Centre in India
Published 2023-06-01Subjects: “…anaplastic lymphoma kinase…”
Get full text
Article -
6
Clinical Efficacy of Crizotinib in Treatment of Patients with Advanced NSCLC
Published 2016-03-01Subjects: Get full text
Article -
7
Ceritinib‐associated hyperglycemia in the Japanese Adverse Drug Event Report Database
Published 2020-05-01Subjects: “…Anaplastic lymphoma kinase…”
Get full text
Article -
8
ROS1 rearrangement and response to crizotinib in Stage IV non-small cell lung cancer
Published 2017-01-01Subjects: “…Anaplastic lymphoma kinase…”
Get full text
Article -
9
A novel intergenic region (chr2: 30,193,816)-ALK fusion shows sensitivity to Alectinib in lung adenocarcinoma
Published 2023-02-01Subjects: “…Anaplastic lymphoma kinase…”
Get full text
Article -
10
The Use of Crizotinib in Sclerosing Epithelioid Fibrosarcoma with ALK Mutation: A Case Report
Published 2023-08-01Subjects: Get full text
Article -
11
Safety and Preliminary Efficacy of Ceritinib 450 mg with Food in Chinese ALK-positive Non-small Cell Lung Cancer
Published 2020-08-01Subjects: Get full text
Article -
12
Treatment of ALK Positive Non-small Cell Lung Cancer with Alectinib: A Case Report and Literature Review
Published 2021-09-01Subjects: “…anaplastic lymphoma kinase…”
Get full text
Article -
13
A New Target in Non-small Cell Lung Cancer: EML4-ALK Fusion Gene
Published 2011-06-01Subjects: Get full text
Article -
14
Cytomorphological features of lung adenocarcinoma with anaplastic lymphoma kinase gene rearrangement
Published 2019-01-01Subjects: “…Anaplastic lymphoma kinase rearrangement…”
Get full text
Article -
15
Inflammatory myofibroblastic tumor directly invading the right first rib treated with oral steroids: a case report
Published 2024-02-01Subjects: Get full text
Article -
16
Inflammatory myofibroblastic tumours of the thorax: Radiologic and clinicopathological correlation
Published 2020-07-01Subjects: “…anaplastic lymphoma kinase-1…”
Get full text
Article -
17
Alectinib-Induced Alopecia in a Patient with Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer
Published 2016-04-01Subjects: “…Anaplastic lymphoma kinase…”
Get full text
Article -
18
ALK-rearranged lung squamous cell carcinoma responding to alectinib: a case report and review of the literature
Published 2017-07-01Subjects: Get full text
Article -
19
Three years sustained complete remission achieved in a primary refractory ALK-positive anaplastic T large cell lymphoma treated with crizotinib
Published 2016-06-01Subjects: Get full text
Article -
20
Treatment of Patients with ALK Gene Rearranged Non-small Cell Lung Cancer after Resistance to Crizotinib
Published 2015-02-01Subjects: Get full text
Article